MedPath

Applied The Platelet Rich Fibrin in Chronic Periodontitis

Phase 2
Completed
Conditions
Chronic Periodontitis
Interventions
Device: Platelet Rich Fibrin
Device: Conventional Flap Surgery
Registration Number
NCT02594605
Lead Sponsor
Ataturk University
Brief Summary

Platelet rich fibrin is a second generation platelet concentration which contains various growth factors. The aim of this study is to evaluate the clinical and biochemical efficacy of PRF in subjects of chronic periodontitis in the operation of conventional periodontal flap.

Detailed Description

PRF was developed in 2001 by Choukroun in France, it was the second generation fibrin adhesive, and was used to accelerate the soft and hard tissue healing. Many studies have shown beneficial effects of PRF on osteoconductive filler material in sinus lift operations, treatment of periodontal sulcus defect and treatment of furcation defects. Also PRF contains many growth factors. PRF accelerates periodontal regeneration through the gradually excreted growth factors and contributes to the bone regeneration. In this study, the investigators evaluated the effect of PRF on growth factors and its contribution to periodontal regeneration in subjects with chronic periodontitis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Patients with CP who had pocket depth ≤ 5 mm and at least two area (grouped as Control and PRF) with horizontal bone loss after Phase I therapy
Exclusion Criteria
  • The subjects excluded in the study had history of systemic disease, were smokers, had allergy to any drug, had need for prophylaxis of antibiotic and had taken antibiotics at least 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Platelet Rich FibrinPlatelet Rich FibrinPlatelet Rich Fibrin was applied with conventional flap surgery for treatment of periodontal bone loss in test group.
Conventional Flap SurgeryConventional Flap SurgeryPlatelet Rich Fibrin was not applied to control groups. Only conventional flap surgery was applied to control groups.
Primary Outcome Measures
NameTimeMethod
Levels of IGF-1, VEGF, BMP-2, FGF-2 on Weekly4 weeks

Change from baseline IGF-1, VEGF, BMP-2, FGF-2 levels of GCF at 1 month were measured by periopaper.

Secondary Outcome Measures
NameTimeMethod
Alteration of Clinical Attachment Level6 month

Change from baseline Clinical Attachment Levels at 6 months were measured with periodontal probe.

Alteration of Periodontal Pocket Depth6 month

Change from baseline Pocket Depth at 6 months were measured with periodontal probe.

Trial Locations

Locations (1)

Alper KIZILDAĞ

🇹🇷

Denizli, Turkey

© Copyright 2025. All Rights Reserved by MedPath